The Trump administration is considering expanding Medicare’s ability to negotiate the cost of drugs by giving private payers a role in setting the price of medicines administered in hospitals and doctors’ offices, Health and Human Services Secretary Alex Azar said on Azar’s comments provided more d...
The post US to consider expanding Medicare drug price negotiation appeared first on Raw Story.
CONTINUE READING >>>